Wealthcare Advisory Partners’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
Wealthcare Advisory Partners's EXAS Position: Q2 2021 in Review
Wealthcare Advisory Partners sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 40 shares — an estimated $5K sold.
Wealthcare Advisory Partners first reported a position in EXAS in Q1 2020 and held it in 2 quarters. The position peaked at $5K in Q1 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.
- Wealthcare Advisory Partners reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
- Wealthcare Advisory Partners sold 40 Exact Sciences shares in Q2 2021, an estimated $5K.
- Wealthcare Advisory Partners first reported a position in Exact Sciences in Q1 2020 and held it in 2 quarters.
- Wealthcare Advisory Partners's Exact Sciences position peaked at $5K in Q1 2021.
- 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.
Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.